biliary disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age: 20 years old or older 2) To consent to an inclusion agreement 3) Patients with altered GI anatomy who have a Biliary disease(suspected)(except for gallstone pancreatitis)
Exclusion criteria
Exclusion criteria: 1) Patients with suspected intestinal perforation 2) Patients with anaphylaxis to natural rubber 3) Patients with a very bad general condition 4) Patients having severe blood clotting defect 5) Patients having severe another disease 6) Gravida and possibly pregnant patients 7) Patients whom the chief physician(or the physician in charge) considers to be inappropriate for entry into the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A success rate of reaching a targeted part (papilla/choledochojejunostomy part) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Judgment of safety (*) 2) A success rate of insertion to deeper parts of a Biliary tract 3) A success rate of treatments relevant to ERC (*)The outcomes described above are determined by a point of view to assess efficacy of DBE regarding treatments of a Biliary tract for patients with altered GI anatomy. The items and classifications about safety are determined as follows by a point of view to assess safety of DBE regarding diagnosis and treatment of a Biliary tract for patients with altered GI anatomy. Grade 1 No problem: There waren't any problems at all. Grade 2 Light problem: There were light problems during or after examination. But it was not necessary to treat specifically. Grade 3 Problem: There were some problems during or after examination. And it was necessary to treat specifically or keep patients in observation. Grade 4 Severe problem: There were severe problems during or after examination. The examination was stopped or should be stopped. Grade 5 Death due to the trial: To describe a reason. | — |
Countries
Japan
Contacts
Kansai Medicine University Division of Gastroenterology and Hepatology